Selection of Trademarks. Celgene shall select the trademark(s) to be used in connection with the marketing and sale of the Licensed Products in the Territory (such marks, together with registrations, applications for registration and common law rights therein, collectively, “Product Trademarks”).
Selection of Trademarks. The JCC shall select the trademark(s) to be used in connection with the marketing and sale of the Licensed Products in the ROW Territory (such marks, together will registrations, applications for registration and common law rights therein, collectively, “Product Trademarks”). Any dispute over the selection of a Product Trademarks shall be presented to the JSC for resolution. The Parties shall adhere to the use of the Product Trademark(s) in their Commercialization of the Licensed Products in the ROW Territory hereunder, to the extent permitted by Law.
Selection of Trademarks. Celgene, following consultation with the JCC and JPC, shall select the trademark(s) to be used in connection with the marketing and sale of the Shared Products in the Territory (such marks, together with registrations, applications for registration and common law rights therein, collectively, “Product Trademarks”). Any dispute over the selection of a Product Trademarks shall be presented to the JSC for resolution. The Parties shall adhere to the use of the Product Trademark(s) in their Commercialization of the Shared Products in the Territory hereunder, to the extent permitted by Law.
Selection of Trademarks. The applicable Lead Party, following consultation with the JCC and JPC, shall select the trademark(s) to be used in connection with the marketing and sale of the Shared Products in the Territory (such marks, together with registrations, applications for registration and common law rights therein, collectively, “Product Trademarks”). Any dispute over the selection of a Product Trademarks shall be presented to the JSC for resolution. The Parties shall adhere to the use of the Product Trademark(s) in their Commercialization of the Shared Products in the Territory hereunder, to the extent permitted by Law.
Selection of Trademarks. Lannett shall select the trademark(s) to be used in connection with the marketing and sale of the Products solely in the US (such marks, together with registrations, applications for registration and common law rights therein, collectively, “US Product Trademarks”).
Selection of Trademarks. Prior to any Co-Development Opt-Out Date, BeiGene, following consultation with the JSC and the Patent Coordinators, shall select the trademark(s) to be used in connection with the marketing and sale of the Products in the Territory (such marks, together with registrations, applications for registration and common law rights therein, collectively, “Product Trademarks”), it being understood that on and after any Co-Development Opt-Out Date, BeiGene will have the sole right in its discretion to select Product Trademarks.
Selection of Trademarks. Xxxxxxx shall have the sole right to choose the trademarks related to the Surgical Products. Xxxxxxx shall provide PLC with copies of the trademarks related to the Surgical Products for review and comment. Xxxxxxx shall be solely responsible for all costs, fees and other expenses associated with the prosecution, maintenance and enforcement of the trademarks related to the Surgical Products and any such applications shall be filed solely in the name of Xxxxxxx and owned solely by Xxxxxxx.
Selection of Trademarks for the Product shall be at BARRIER's sole discretion and BARRIER shall own all right, title and interest in and to any and all such Trademarks.
Selection of Trademarks. Xxxxxxx shall select the trademark(s) to be used in connection with the marketing and sale of the Products solely in the US (such marks, together with registrations, applications for registration and common law rights therein, collectively, “US Product Trademarks”).
Selection of Trademarks. Anesta shall have the right to select additional Anesta Trademarks and register them at its expense, and such Anesta Trademarks shall be owned by Anesta and added to Exhibit D, initially as secondary Anesta Trademarks. If (i) a regulatory agency does not approve the then-current primary Anesta Trademark indicated on Exhibit D, (ii) a Third Party asserts that such Anesta Trademark infringes its trademarks, (iii) such Anesta Trademark is successfully opposed by a Third Party, (iv) a petition to cancel such Anesta Trademark is filed by a Third Party, or (v) there is an infringement of such Anesta Trademark by any Third Party against which Anesta does not enforce its rights pursuant to Section 2.9(f), then Anesta shall
